Event at-a-glance
The EuroPotent Therapeutics Summit, hosted by Veridon Global is set to convene leading experts, innovators, and decision-makers in the field of high-potency active pharmaceutical ingredients (HPAPI) and potent therapeutic development. It will take place on 22nd-23rd May 2025 in Frankfurt, Germany, offering an unparalleled platform for professionals in the pharmaceutical and biotech sectors to explore the latest developments in HPAPI. With Europe at the forefront of global regulatory standards, this summit will provide a comprehensive overview of the evolving regulatory landscape, with a focus on compliance challenges, emerging technologies, and cutting-edge safety practices specific to HPAPI manufacturing. Key themes will include advancements in containment and isolation technologies, environmental sustainability, and the integration of digital tools to optimize production processes while ensuring safety and regulatory adherence.
This summit will bring together leading experts and innovators to address the most pressing issues in the HPAPI sector, such as workforce training, exposure control, and maintaining the highest standards of quality in the production of highly potent therapeutics. Through a combination of case studies and panel discussions, participants will gain practical insights into overcoming the complexities of handling potent compounds and achieving operational excellence in a highly regulated market. By fostering collaboration and knowledge exchange, the event will empower stakeholders to tackle the challenges of HPAPI production, develop effective strategies for the future, and strengthen their competitive edge in the European market.
Key Topics
- Navigating EU regulations on HPAPI manufacturing, containment, and transportation
- Advanced containment strategies for HPAPI facilities
- Ensuring supply chain resilience for high-potency APIs within Europe
- Utilizing machine learning and process analytical technology (PAT) for precision in HPAPI production
- Waste management and environmental sustainability in HPAPI production
- Risk assessment for high-potency substances in European facilities
- Best practices for collaborating with CMOs in Europe
Why join us?
- Regulatory Insights Stay informed on the latest European HPAPI regulations and compliance strategies.
- Expert-Led Discussions Learn from industry leaders about the newest advancements in HPAPI safety, containment, and production technologies.
- Innovative Solutions Discover cutting-edge tools and techniques for optimizing HPAPI manufacturing processes and enhancing safety.
- Networking Opportunities Build valuable connections with key professionals, potential partners, and thought leaders in the HPAPI and pharmaceutical sectors
- Practical Knowledge Gain actionable strategies and best practices to implement at your organization for improved quality, efficiency, and regulatory compliance.
Target Audience
The EuroPotent Therapeutics Summit is tailored for professionals within the pharmaceutical and biotechnology industries who are engaged in the development, production, and regulation of high-potency active pharmaceutical ingredients (HPAPI). The key target audience includes:
- HPAPI Production Managers/Heads
- Process Development Engineers
- Regulatory Affairs Managers/Heads
- Research and Development Managers/Heads
- Quality Assurance and Control Professionals
- Occupational Safety and Health (HSE/EHS) Professionals
- Supply Chain Managers/Heads
- Pharmaceutical Consultants
